Mindray Medical International Limited (NYSE:MR)

CAPS Rating: 3 out of 5

The Company is a developer, manufacturer and marketer of medical devices in China.

Recs

0
Player Avatar firestargal (< 20) Submitted: 12/2/2010 9:44:46 AM : Outperform Start Price: $25.85 MR Score: +10.20

oversold.

Featured Broker Partners


Advertisement